Elanco Animal Health Incorporated (ELAN) Price Target Analysis
Updated Jun 18, 2026
Analyst Rating: Buy
Based on 20 analysts17.3% Below Target
ELAN trades 17.3% below Wall Street's consensus target of $28.40.
Current Price$24.22
Average Target$28.40
Target
Current
Low$23.00
Median$30.00
High$30.00
Analyst Target Range
Forward P/E22.9x
(Fair)
PEG Ratio—
Implied Growth+321.3%
(High Growth)
Analyst Spread24.6%
(High Agreement)
Price Forecast (1 Year)
Last 12 months price action with 12-month analyst target path
Consensus Scenario Assumptions
The base valuation assumes ELAN achieves its forward estimates and maintains a stable P/E multiple of 22.9x. This scenario reflects the blended consensus of 20 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
ELAN Price Target Analysis
Updated June 21, 2026As of June 21, 2026, Elanco Animal Health Incorporated (ELAN) has a Wall Street consensus price target of $28.40, based on estimates from 20 covering analysts. With the stock currently trading at $24.22, this represents a potential upside of +17.3%. The company has a market capitalization of $12.10B.
Analyst price targets range from a low of $23.00 to a high of $30.00, representing a 25% spread in expectations. The median target of $30.00 differs from the mean, suggesting potential outlier estimates. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 14 analysts rating the stock as a Buy or Strong Buy,4 rating it Hold, and 2 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, ELAN trades at a trailing P/E of -51.5x and forward P/E of 22.9x. Analysts expect EPS to grow +321.3% over the next year.
Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.
Analyst Sentiment Comparison
Industry Peer AnalysisAvg Peer Upside
+37.3%
Industry Consensus
Avg Forward P/E
16.3x
(Fair)
Peers with Coverage
9 / 10
Active Analyst Tracking
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 ZTSZoetis Inc. | $33.0B | $78.71 | $120.80 | +53.5% | Hold | 11.4x | 30 |
 PCRXPacira BioSciences, Inc. | $878M | $22.33 | $32.00 | +43.3% | Hold | 7.8x | 36 |
 PAHCPhibro Animal Health Corporation | $1.3B | $31.85 | $49.00 | +53.8% | Buy | 10.4x | 14 |
 NEOGNeogen Corporation | $2.0B | $9.31 | $11.00 | +18.2% | Hold | 25.2x | 11 |
 PETSPetMed Express, Inc. | $37M | $1.75 | — | — | — | — | — |
 CHWYChewy, Inc. | $7.5B | $18.21 | $31.54 | +73.2% | Buy | 23.1x | 38 |
 ANIPANI Pharmaceuticals, Inc. | $1.8B | $79.49 | $124.00 | +56.0% | Buy | 8.5x | 10 |
 LLYEli Lilly and Company | $1.0T | $1098.13 | $1271.24 | +15.8% | Buy | 30.0x | 45 |
 PFEPfizer Inc. | $143.5B | $25.22 | $26.75 | +6.1% | Hold | 8.5x | 39 |
 MRKMerck & Co., Inc. | $281.2B | $113.87 | $131.58 | +15.6% | Buy | 22.2x | 37 |
ELAN — Frequently Asked Questions
Quick answers to the most common questions about buying ELAN stock.
What is the ELAN stock price target for 2026?
Elanco Animal Health Incorporated (ELAN) has a consensus 12-month price target of $28.4, implying 17.3% upside from $24.22. The 20 analysts covering ELAN see moderate appreciation potential.
Is ELAN a buy, sell, or hold?
ELAN has a consensus rating of "Buy" based on 20 Wall Street analysts. The rating breakdown is predominantly bullish, with 14 Buy/Strong Buy ratings. The consensus 12-month price target of $28.4 implies 17.3% upside from current levels.
Is ELAN stock overvalued or undervalued?
ELAN trades at a forward P/E of 22.8858x, representing a moderate valuation. With analysts targeting $28.4 (17.3% implied move), the stock appears reasonably valued with upside.
How high can ELAN stock go?
The most bullish Wall Street analyst has a price target of $30 for ELAN, while the most conservative target is $23. The consensus of $28.4 represents the median expectation. These targets typically reflect 12-month expectations.
How many analysts cover ELAN stock?
ELAN is well covered by analysts, with 20 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 14 have Buy ratings, 4 recommend Hold, and 2 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
What is the ELAN stock forecast?
The 12-month ELAN stock forecast based on 20 Wall Street analysts shows a consensus price target of $28.4, with estimates ranging from $23 (bear case) to $30 (bull case). The median consensus rating is "Buy".
What is ELAN's forward P/E ratio?
ELAN trades at a forward P/E ratio of 22.9x based on next-twelve-months earnings estimates. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Should I buy ELAN stock?
Wall Street analysts are optimistic on ELAN, with a "Buy" consensus rating and $28.4 price target (17.3% upside). 14 of 20 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
Why do ELAN price targets vary so much?
ELAN analyst price targets range from $23 to $30, a 25% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $28.4 consensus represents the middle ground.
Consensus-Based Analysis Tools
Full Stock Analysis
Deep dive into ELAN consensus models and risk factors.
View Analysis
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Check Valuation
Historical Returns
10-year return with dividends reinvested.
Calculate
DCA Calculator
See how regular investing compounds over time.
Run Numbers
Peer Comparison
Compare growth, multiples, and margins vs sector.
Compare